Imricor Medical Systems' NorthStar Mapping System Achieves Technical Goals in Philips Testing; Shares Nearly Hit Three-Year High

MT Newswires Live

Oct 18, 2024

Imricor Medical Systems (ASX:IMR) said all technical goals of the sensing and image-guided neurological therapies, cardiac electrophysiology, and tumor Treatments consortium related to its NorthStar 3D mapping system operating on Philips Medical Systems' MRI platform were achieved during testing, according to a Thursday filing with the Australian Securities Exchange.

The testing was conducted over 14 hours at Amsterdam University Medical Center on Oct. 10, the filing said.

Philips and the company are now working on full commercialization efforts for NorthStar on the Philips platform, according to the filing.

Imricor Medical Systems' shares rose 8% in morning trade Friday and earlier hit their highest since January 2022.

Price (AUD): $0.80, Change: $+0.060, Percent Change: +8.11%

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2476649313"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2476649313\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2476649313?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-10-18 08:53","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2476649313","market":"sh","top_or_hot":-1,"title":"Imricor Medical Systems' NorthStar Mapping System Achieves Technical Goals in Philips Testing; Shares Nearly Hit Three-Year High","media":"MT Newswires Live","content":"<html><body><p> Imricor Medical Systems (ASX:IMR) said all technical goals of the sensing and image-guided neurological therapies, cardiac electrophysiology, and tumor Treatments consortium related to its NorthStar 3D mapping system operating on Philips Medical Systems' MRI platform were achieved during testing, according to a Thursday filing with the Australian Securities Exchange.</p><p>The testing was conducted over 14 hours at Amsterdam University Medical Center on Oct. 10, the filing said.</p><p>Philips and the company are now working on full commercialization efforts for NorthStar on the Philips platform, according to the filing.</p><p>Imricor Medical Systems' shares rose 8% in morning trade Friday and earlier hit their highest since January 2022.</p><p>Price (AUD): $0.80, Change: $+0.060, Percent Change: +8.11%</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Imricor Medical Systems' NorthStar Mapping System Achieves Technical Goals in Philips Testing; Shares Nearly Hit Three-Year High</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nImricor Medical Systems' NorthStar Mapping System Achieves Technical Goals in Philips Testing; Shares Nearly Hit Three-Year High\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2024-10-18 08:53</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> Imricor Medical Systems (ASX:IMR) said all technical goals of the sensing and image-guided neurological therapies, cardiac electrophysiology, and tumor Treatments consortium related to its NorthStar 3D mapping system operating on Philips Medical Systems' MRI platform were achieved during testing, according to a Thursday filing with the Australian Securities Exchange.</p><p>The testing was conducted over 14 hours at Amsterdam University Medical Center on Oct. 10, the filing said.</p><p>Philips and the company are now working on full commercialization efforts for NorthStar on the Philips platform, according to the filing.</p><p>Imricor Medical Systems' shares rose 8% in morning trade Friday and earlier hit their highest since January 2022.</p><p>Price (AUD): $0.80, Change: $+0.060, Percent Change: +8.11%</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK7503","symbol_name":"科技股","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2476649313","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2476649313","pubTimestamp":1729212794,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Imricor Medical Systems  said all technical goals of the sensing and image-guided neurological therapies, cardiac electrophysiology, and tumor Treatments consortium related to its NorthStar 3D mapping system operating on Philips Medical Systems' MRI platform were achieved during testing, according to a Thursday filing with the Australian Securities Exchange.The testing was conducted over 14 hours at Amsterdam University Medical Center on Oct. 10, the filing said.Philips and the company are now working on full commercialization efforts for NorthStar on the Philips platform, according to the filing.Imricor Medical Systems' shares rose 8% in morning trade Friday and earlier hit their highest since January 2022.Price : $0.80, Change: $+0.060, Percent Change: +8.11%","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK7503":"科技股","BK4125":"广播","BK7508":"医药生物股","IMR.AU":"IMRICOR MEDICAL SYSTEMS-CDI","BK7007":"医疗保健设备"},"translate_title":"Imricor Medical Systems的NorthStar标测系统实现了飞利浦测试中的技术目标；股价几乎创下三年新高","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"IMR.AU":0.9,"AUD":1},"content_text":"Imricor Medical Systems (ASX:IMR) said all technical goals of the sensing and image-guided neurological therapies, cardiac electrophysiology, and tumor Treatments consortium related to its NorthStar 3D mapping system operating on Philips Medical Systems' MRI platform were achieved during testing, according to a Thursday filing with the Australian Securities Exchange.The testing was conducted over 14 hours at Amsterdam University Medical Center on Oct. 10, the filing said.Philips and the company are now working on full commercialization efforts for NorthStar on the Philips platform, according to the filing.Imricor Medical Systems' shares rose 8% in morning trade Friday and earlier hit their highest since January 2022.Price (AUD): $0.80, Change: $+0.060, Percent Change: +8.11%","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}